Results 151 to 160 of about 110,621 (200)

Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis. [PDF]

Int J Mol Sci
Panikar SS, Bansal D, Crandall J, Raman H, Picus J, Ippolito JE, Thorek DLJ, Wahl R, Pachynski RK.   +8 more
europepmc   +1 more source

Application of carbonic anhydrase IX-targeted radiopharmaceuticals in the diagnosis and treatment of clear cell renal cell carcinoma (Review). [PDF]

Oncol Lett
Wang M, Li Y, Yang W, Liu B.
europepmc   +1 more source

Emerging Near-Infrared Targeted Imaging Pharmaceutics for Ovarian Cancer. [PDF]

Pharmaceutics
Phillip A, Karithara A, Chauhan SC, Yallapu MM.   +3 more
europepmc   +1 more source

Recurrent Radiation-Induced Angiosarcoma of the Breast Without Distant Metastasis: A Case Report. [PDF]

Cureus
Bivolarski I, Dimitrov M.
europepmc   +1 more source

First-in-human <i>ex-vivo</i> validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493). [PDF]

Theranostics
Larcher A, Gelardi F, Antunovic L, Savi A, Olivieri M, Rainone P, Sollini M, Moresco RM, Re C, Cei F, Belladelli F, Musso G, Salerno L, De Cobelli F, Tenace N, Ponzoni M, Cigliola A, Verze P, Bertini R, Briganti A, Montorsi F, Capitanio U, Salonia A, Chiti A.   +23 more
europepmc   +1 more source

Nectin-4-Targeted Radiotheranostics for Personalized Cancer Therapy: A Systematic Review. [PDF]

J Nucl Med
Schäfer L, Altunay B, Morgenroth A, Vogg A, Derks Y, Lammers T, Peña Q, Mottaghy FM, Lütje S.   +8 more
europepmc   +1 more source

Effects of Biologic Therapies and Narrowband UVB Phototherapy on Vascular Inflammation and Systemic Inflammatory Biomarkers in Psoriasis: A Systematic Review and Narrative Synthesis of Prospective Studies. [PDF]

J Clin Med
Toma AO, Crainic D, Mateescu DM, Fericean RM, Pilut NC, Ivanovic N, Serban DV.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Radiolabelled Agents for PET Imaging of Tumor Hypoxia

Current Medicinal Chemistry, 2012
Hypoxia has been observed in a variety of human tumor types and evaluating tumor hypoxia is important because it increases resistance to radiotherapy and chemotherapy by inducing proteomic change that allow the tumor cell to survive in their hypoxic environment.
H, Kurihara, N, Honda, Y, Kono, Y, Arai
openaire   +2 more sources

New PET imaging agents in the management of solid cancers

Current Opinion in Oncology, 2012
(18)F-fluoro-2-deoxy-D-glucose PET-computed tomography (CT) has a major clinical impact in oncology not only for diagnostics but also for staging, response assessment, and relapse detection. However, several other PET tracers are needed for a more complete molecular characterization of cancers which has great importance in the era of individualized ...
Garcia, Camilo, Gebhart, Géraldine, Flamen, Patrick   +2 more
openaire   +3 more sources

55Cobalt complexes with pendant carbohydrates as potential PET imaging agents

Applied Radiation and Isotopes, 2007
Bis-ligand cobalt(II) complexes of four 3-hydroxy-4-pyridinone ligands with pendant carbohydrates were synthesized and examined for their potential as radiopharmaceuticals. Non-radioactive complexes were prepared on the macroscopic scale and characterized by elemental analysis, mass spectrometry, IR and UV/visible spectroscopy.
Cara L, Ferreira, Suzanne, Lapi, Jennifer, Steele, David E, Green, Thomas J, Ruth, Michael J, Adam, Chris, Orvig   +6 more
openaire   +2 more sources